Funder
National Natural Science Foundation of China
Publisher
Springer Science and Business Media LLC
Reference165 articles.
1. Sun L, Wang GW, Guo WY. Advances in the study of hyperuricemia. Chin J Gerontol. 2017;37(4):1034–8.
2. Liu N, Xu H, Sun Q, Yu X, Chen W, Wei H, et al. The role of oxidative stress in Hyperuricemia and Xanthine Oxidoreductase (XOR) Inhibitors. Tocchetti CG (ed.). Oxidative Med Cell Longev. 2021;2021:1–15.
3. Feng WW, Cui D, Yang T. Highlights of the Chinese Guidelines for the Management of Hyperuricemia and Gout (2019). J Clin Int Med. 2020;37(7):528–31.
4. Zhang M, Zhu X, Wu J, Huang Z, Zhao Z, Zhang X, et al. Prevalence of Hyperuricemia Among Chinese Adults: Findings From Two Nationally Representative Cross-Sectional Surveys in 2015–16 and 2018–19. Front Immunol. 2022;12:791983. https://doi.org/10.3389/fimmu.2021.791983.
5. Dalbeth N, Gosling AL, Gaffo A, Abhishek A. Gout. The Lancet. 2021;397(10287):1843–55. https://doi.org/10.1016/S0140-6736(21)00569-9.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Gout in history of humanity;Rheumatology Science and Practice;2024-06-26